Get the Stockscreener App
13.51
2.43%
0.32
Wave Life Sciences Ltd stock is traded at $13.51, with a volume of 3.87M.
It is up +2.43% in the last 24 hours and down -5.26% over the past month.
WAVE Life Sciences Ltd is unlocking the broad potential of RNA medicines also known as oligonucleotides, it targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISMTM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, splicing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.
See More
Previous Close:
$13.19
Open:
$13.06
24h Volume:
3.87M
Relative Volume:
1.99
Market Cap:
$2.06B
Revenue:
$113.31M
Net Income/Loss:
$-57.51M
P/E Ratio:
-9.9338
EPS:
-1.36
Net Cash Flow:
$-20.55M
1W Performance:
+0.52%
1M Performance:
-5.26%
6M Performance:
+161.82%
1Y Performance:
+181.46%
1-Day Range:
$12.93
$13.85
1-Week Range:
$12.84
$14.57
52-Week Range:
$3.50
$16.73
Wave Life Sciences Ltd Stock (WVE) Company Profile
Name
Wave Life Sciences Ltd
Sector
Industry
Phone
617-949-2900
Address
7 STRAITS VIEW, SINGAPORE
Compare WVE with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
WVE
Wave Life Sciences Ltd
|
13.51 | 2.06B | 113.31M | -57.51M | -20.55M | -0.55 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.27 | 102.31B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
701.85 | 77.13B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
623.82 | 37.30B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
245.44 | 31.66B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
113.08 | 27.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Wave Life Sciences Ltd Stock (WVE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-16-24 | Upgrade | Raymond James | Outperform → Strong Buy |
| Sep-27-24 | Resumed | JP Morgan | Overweight |
| Sep-19-24 | Initiated | B. Riley Securities | Buy |
| Sep-09-24 | Initiated | JP Morgan | Overweight |
| May-15-24 | Initiated | Wells Fargo | Overweight |
| Dec-19-23 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Jul-05-23 | Initiated | Raymond James | Outperform |
| May-24-23 | Downgrade | Jefferies | Buy → Hold |
| Dec-15-20 | Resumed | H.C. Wainwright | Buy |
| Oct-23-20 | Initiated | RBC Capital Mkts | Sector Perform |
| Dec-31-19 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Nov-01-19 | Initiated | Guggenheim | Buy |
| Jul-15-19 | Initiated | Cowen | Market Perform |
| Apr-17-19 | Reiterated | H.C. Wainwright | Buy |
| Aug-07-18 | Initiated | Stifel | Buy |
| Jul-23-18 | Initiated | H.C. Wainwright | Buy |
| Mar-19-18 | Reiterated | Mizuho | Buy |
| Feb-15-17 | Initiated | H.C. Wainwright | Buy |
| Nov-10-16 | Resumed | Leerink Partners | Outperform |
| Dec-07-15 | Initiated | JMP Securities | Mkt Outperform |
| Dec-07-15 | Initiated | Jefferies | Buy |
| Dec-07-15 | Initiated | Leerink Partners | Outperform |
| Dec-07-15 | Initiated | Sun Trust Rbsn Humphrey | Buy |
View All
Wave Life Sciences Ltd Stock (WVE) Latest News
WAVE Life Sciences (FRA:1U5) Other Long-Term Liabilities : €7.09 Mil (As of Sep. 2024) - GuruFocus.com
WAVE Life Sciences (FRA:1U5) Dividend Payout Ratio : 0.00 (As of Sep. 2024) - GuruFocus.com
Comprehensive Market Analysis of Latest Published 9 Rare Genetic Disorders Reports | DelveInsight - GlobeNewswire Inc.
(WVE) Investment Analysis - Stock Traders Daily
Y Intercept Hong Kong Ltd Has $242,000 Stock Holdings in Wave Life Sciences Ltd. (NASDAQ:WVE) - MarketBeat
Wellington Management Group LLP Reduces Position in Wave Life Sciences Ltd. (NASDAQ:WVE) - MarketBeat
Wave Life Sciences Ltd. (NASDAQ:WVE) Receives Average Recommendation of "Buy" from Brokerages - MarketBeat
Wave Life Sciences to Present at 43rd Annual J.P. Morgan Healthcare Conference - The Manila Times
WaVe Life Sciences' SWOT analysis: RNA editing pioneer's stock faces pivotal year - Investing.com Australia
Point72 Asset Management L.P. Has $230,000 Holdings in Wave Life Sciences Ltd. (NASDAQ:WVE) - MarketBeat
Neurological stocks rise and fall on clinical data; index down - BioWorld Online
Fmr LLC Raises Stock Holdings in Wave Life Sciences Ltd. (NASDAQ:WVE) - MarketBeat
Wave Life Sciences Ltd. (NASDAQ:WVE) Shares Purchased by Charles Schwab Investment Management Inc. - MarketBeat
Can Sai Life Sciences ride the global CRDMO wave? A detailed IPO analysis - Dalal Street Investment Journal
Jacobs Levy Equity Management Inc. Sells 262,075 Shares of Wave Life Sciences Ltd. (NASDAQ:WVE) - MarketBeat
Duchenne Muscular Dystrophy Pipeline Insights 2024: - openPR
RTW Investments LP Makes New Investment in Wave Life Sciences Ltd. (NASDAQ:WVE) - MarketBeat
486,023 Shares in Wave Life Sciences Ltd. (NASDAQ:WVE) Acquired by Polar Asset Management Partners Inc. - MarketBeat
Maven Securities LTD Purchases Shares of 850,000 Wave Life Sciences Ltd. (NASDAQ:WVE) - MarketBeat
Cinctive Capital Management LP Has $2.92 Million Stake in Wave Life Sciences Ltd. (NASDAQ:WVE) - MarketBeat
Baker BROS. Advisors LP Invests $2.82 Million in Wave Life Sciences Ltd. (NASDAQ:WVE) - MarketBeat
Walleye Capital LLC Invests $4.94 Million in Wave Life Sciences Ltd. (NASDAQ:WVE) - MarketBeat
WAVE Life Sciences (STU:1U5) Pre-Tax Income : €-130.19 Mil (TTM As of Sep. 2024) - GuruFocus.com
WAVE Life Sciences (FRA:1U5) Financial Strength : 6 (As of Sep. 2024) - GuruFocus.com
Learn to Evaluate (WVE) using the Charts - Stock Traders Daily
Wave Life Sciences CEO Paul Bolno sells $750,000 in shares - Investing.com India
Wave Life Sciences CEO Paul Bolno sells $750,000 in shares By Investing.com - Investing.com Canada
Wave Life Sciences to Present at Upcoming Investor Conferences - The Manila Times
Wave Life Sciences CEO to Present at Evercore and Citi Healthcare Conferences | WVE Stock News - StockTitan
Wave Life Sciences Ltd. (NASDAQ:WVE) Receives $22.22 Average Price Target from Brokerages - MarketBeat
Primecap Management Co. CA Decreases Stake in Wave Life Sciences Ltd. (NASDAQ:WVE) - MarketBeat
Wave Life Sciences (NASDAQ:WVE) Price Target Raised to $22.00 - MarketBeat
Wave Life Sciences Advances RNA Medicine Innovations - TipRanks
B. Riley Cuts Earnings Estimates for Wave Life Sciences - MarketBeat
HC Wainwright Has Pessimistic Outlook of WVE FY2024 Earnings - MarketBeat
Trading (WVE) With Integrated Risk Controls - Stock Traders Daily
Insider Sale: President and CEO Paul Bolno Sells 51,234 Shares o - GuruFocus.com
Wave Life Sciences Ltd. (NASDAQ:WVE) CEO Sells $733,670.88 in Stock - MarketBeat
Wave Life Sciences CEO Paul Bolno sells shares for $733,670 By Investing.com - Investing.com UK
Wave Life Sciences CEO Paul Bolno sells shares for $733,670 - Investing.com India
WVEWave Life Sciences Ltd. Ordinary Shares Latest Stock News & Market Updates - StockTitan
What is HC Wainwright's Forecast for WVE FY2028 Earnings? - MarketBeat
Wave Life Sciences to Present at Jefferies London Healthcare Conference - The Manila Times
What is B. Riley's Estimate for WVE Q1 Earnings? - MarketBeat
US$22.20That's What Analysts Think Wave Life Sciences Ltd. (NASDAQ:WVE) Is Worth After These Results - Simply Wall St
Wave Life Sciences Ltd. (NASDAQ:WVE) Released Earnings Last Week And Analysts Lifted Their Price Target To US$22.20 - Yahoo Finance
Leerink Partnrs Has Bullish Forecast for WVE FY2024 Earnings - MarketBeat
Wave Life Sciences Ltd Stock (WVE) Financials Data
Revenue
Net Income
Cash Flow
EPS
Wave Life Sciences Ltd Stock (WVE) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| BOLNO PAUL | President and CEO |
Nov 25 '24 |
Sale |
15.00 |
50,000 |
750,000 |
217,351 |
2.88%
2.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):